E

EyePoint Pharmaceuticals
D

EYPT

5.67500
USD
0.07
(1.16%)
مغلق
حجم التداول
20,171
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
390,506,602
أصول ذات صلة
ABBV
ABBV
0.810
(0.44%)
183.260 USD
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
BMY
BMY
-0.140
(-0.30%)
46.870 USD
CVS
CVS
0.670
(1.11%)
60.850 USD
GE
GE
2.540
(1.10%)
232.800 USD
HCA
HCA
-0.20
(-0.05%)
376.63 USD
IBM
IBM
-0.06
(-0.02%)
258.71 USD
LLY
LLY
-7.85
(-1.09%)
713.61 USD
UNH
UNH
-4.34
(-1.45%)
295.57 USD
المزيد
الأخبار المقالات

العنوان: EyePoint Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.